Significance of resistance training for the attenuation of skeletal myopathy in chronic heart failure;Znaczenie treningu oporowego w redukcji miȩśniowych nastȩpstw niewydolności serca

Kardiologia Polska

Volumn 66, Issue 4, 2008, Pages 434-442

  Wȩgrzynowska Teodorczyk, Kinga ^a,b   Jankowska, Ewa A ^b,c   Banasiak, Waldemar ^b   Ponikowski, Piotr ^b   Woźniewski, Marek ^a  

^a UNIVERSITY SCHOOL OF PHYSICAL EDUCATION   (Poland)

^b Samodzielny Publiczny Zespó Opieki Zdrowotnej   (Poland)

^c Polish Academy of Sciences   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AEROBIC EXERCISE; ATTENUATION; ENERGY; HEART FAILURE; MEDICAL LITERATURE; MUSCLE FUNCTION; MUSCLE STRENGTH; MYOPATHY; PATHOPHYSIOLOGY; REVIEW; SKELETAL MUSCLE; TRAINING; HUMAN; KINESIOTHERAPY;

EXERCISE THERAPY; HEART FAILURE; HUMANS; MUSCLE, SKELETAL;

EID: 50049093347     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Review

References (92)

1. Bleumink GS, Knetsch AM, Sturkenboom MC, et al. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study. Eur Heart J 2004; 25: 1614-9.
2. Stewart S, MacIntyre K, Capewell S, et al. Heart failure and the aging population: an increasing burden in the 21st century? Heart 2003; 89: 49-53.
3. Wilhelmsen L, Rosengren A, Eriksson H, et al. Heart failure in the general population of men - morbidity, risk factors and prognosis. J Intern Med 2001; 249: 253-61.
4. Ho KK, Pinsky JL, Kannel WB, et al. The epidemiology of hart failure: The Framingham study. J Am Coll Cardiol 1993; 22 (Suppl 2): 6A-13A.
5. Ponikowski P, Petruk-Kowalczyk J, Banasiak W. Udział miȩśni szkieletowych w patogenezie nietolerancji wysiłku w niewydolności serca. Kardiol Pol 2000; 53: 101-8.
6. Coats AJ, Clark AL, Piepoli M, et al. Symptoms and quality of life in heart failure: the muscle hypothesis. Br Heart J 1994, 72 (Suppl): S36-9.
7. Jankowska EA, Ponikowski P, Piepoli MF, et al. Autonomic imbalance and immune activation in chronic heart failure - pathophysiological links. Cardiovasc Res 2006; 70: 434-45.
8. Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 1992; 20: 248-54.
9. Anker SD, Chua TP, Ponikowski P, et al. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 1997; 96: 526-34.
10. Mann DL. Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res 2002; 91: 988-98.
11. Coats AJ. Heart failure: What causes the symptoms of heart failure? Heart 2001; 86: 574-78.
12. Yndestad A, Damås JK, Øie E, et al. Role of inflammation in the progression of heart failure. Curr Cardiol Rep 2007; 9: 236-41.
13. Itoh K, Osada N, Inoue K, et al. Relationship between exercise intolerance and levels of neurohormonal factors and proinflammatory cytokines in patients with stable chronic heart failure. Int Heart J 2005; 46: 1049-59.
14. Kinugawa T, Kato M, Ogino K, et al. Neurohormonal determinants of peak oxygen uptake in patients with chronic heart failure. Jpn Heart J 2003; 44: 725-34.
15. Piepoli M, Ponikowski P, Clark AL, et al. A neural link to explain the 'muscle hypothesis' of exercise intolerance in chronic heart failure. Am Heart J 1999; 137: 1050-6.
16. Kaczmarek A, Jankowska EA, Witkowski T, et al. Przewlekła niewydolnośś serca. Wzmożona aktywność ergoreceptorów miȩśni szkieletowych a nietolerancja wysiłku. Kardiol Pol 2004; 60: 328-32.
17. Anker SD, Clark AL, Teixeira MM, et al. Loss of bone mineral in patients with cachexia due to chronic heart failure. Am J Cardiol 1999; 83: 612-5.
18. Anker SD, Sharma R. The syndrome of cardiac cachexia. Int J Cardiol 2002; 85: 51-66.
19. Anker SD, Coats AJ. Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation. Chest 1999; 115: 836-47.
20. Filippatos GS, Anker SD, Kremastinos DT. Pathophysiology of peripheral muscle wasting in cardiac cachexia. Curr Opin Clin Nutr Metab Care 2005; 8: 249-54.
21. Anker S, Negassa A, Coats A, et al. Weight loss in chronic heart failure (CHF) and the impact of treatment with ACE inhibitors - Results from the SOLVD treatment trial. Circulation 1999; 100: I-781 (abstract).
22. Anker SD, Negassa A, Coats AJ, et al. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet 2003; 361: 1077-83.
23. Anker SD, Ponikowski P, Varney S, et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet 1997; 349: 1050-53.
24. Massie BM, Conway M, Rajagopalan B, et al. Skeletal muscle metabolism during exercise under ischemic conditions in congestive heart failure. Evidence for abnormalities unrelated to blood flow. Circulation 1988; 78: 320-6.
25. Okita K, Yonezawa K, Nishijima H, et al. Muscle high-energy metabolites and metabolic capacity in patients with heart failure. Med Sci Sports Exerc 2001; 33: 442-8.
26. Morkin E. Regulation of myosin heavy chain genes in the heart. Circulation 1993; 87: 1451-60.
27. Vescovo G, Ambrosio GB, Dalla Libera L. Apoptosis and changes in contractile protein pattern in the skeletal muscle in heart failure. Acta Physiol Scand 2001; 171: 305-10.
28. Sullivan MJ, Duscha BD, Klitgaard H, et al. Altered expression of myosin heavy chain in human skeletal muscle in chronic heart failure. Med Sci Sport Exerc 1997; 29: 860-6.
29. Lipkin DP, Jones DA, Round JM, et al. Abnormalities of skeletal muscle in patients with chronic heart failure. Int J Cardiol 1988; 18: 187-95.
30. Mancini DM, Coyle E, Coggan A, et al. Contribution of intrinsic skeletal muscle changes to 31P NMR skeletal muscle metabolic abnormalities in patients with chronic heart failure. Circulation 1989; 80: 1338-46.
31. Adams V, Jiang H, Yu J, et al. Apoptosis in skeletal myocytes of patients with chronic heart failure is associated with exercise intolerance. Am J Coll Cardiol 1999; 33: 959-65.
32. Krown KA, Page MT, Nguyen C, et al. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest 1996; 98: 2854-65.
33. Vescovo G, Volterrani M, Zennaro R, et al. Apoptosis in the skeletal muscle of patients with heart failure: investigation of clinical and biochemical changes. Heart 2000; 84: 431-7.
34. Mancini DM, Walter G, Reichek N, et al. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation 1992; 85: 1364-73.
35. Drexler H, Riede U, Münzel T, et al. Alterations of skeletal muscle in chronic heart failure. Circulation 1992; 85: 1751-9.
36. Hasselgren PO, Fischer JE. Muscle cachexia: current concepts of intracellular mechanisms and molecular regulation. Ann Surg 2001; 233: 9-17.
37. Anker SD, Ponikowski P, Clark AL, et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure. Eur Heart J 1999; 20: 683-93.
38. Sharma R, Anker SD. Cytokines, apoptosis and cachexia: the potential for TNF antagonism. Int J Cardiol 2002; 85: 161-71.
39. Schulze PC, Gielen S, Adams V, et al. Muscular levels of proinflammatory cytokines correlate with a reduced expression of insulinlike growth factor-I in chronic heart failure. Basic Res Cardiol 2003; 98: 267-74.
40. Hambrecht R, Schulze PC, Gielen S, et al. Reduction of insulin-like growth factor-I expression in the skeletal muscle of noncachectic patients with chronic heart failure. J Am Coll Cardiol 2002; 39: 1175-81.
41. Jankowska EA, Biel B, Majda J, et al. Anabolic deficiency in men with chronic heart failure. Prevalence and detrimental impact on survival. Circulation 2006; 114: 1829-37.
42. Degache F, Garet M, Calmels P, et al. Enhancement of isokinetic muscle strength with a combined training programme in chronic heart failure. Clin Physiol Funct Imaging 2007; 27: 225-30.
43. Delagardelle C, Feiereisen P, Autier P, et al. Strength/endurance training versus endurance training in congestive heart failure. Med Sci Sports Exerc 2002; 34: 1868-72.
44. Dobsák P, Nováková M, Siegelová J, et al. Low-frequency electrical stimulation increases muscle strength and improves blood supply in patients with chronic heart failure. Circ J 2006; 70: 75-82.
45. Suzuki K, Omiya K, Yamada S, et al. Relations between strength and endurance of leg skeletal muscle and cardiopulmonary exercise testing parameters in patients with chronic heart failure. J Cardiol 2004; 43: 59-68.
46. Hülsmann M, Quittan M, Berger R, et al. Muscle strength as a predictor of long-term survival in severe congestive heart failure. Eur J Heart Fail 2004; 16: 101-7.
47. Selig SE, Carey MF, Menzies DG, et al. Reliability of isokinetic strength and aerobic power testing for patients with chronic heart failure. J Cardiopulm Rehabil 2002; 22: 282-9.
48. Beniaminovitz A, Lang CC, LaManca J, et al. Selective low-level leg muscle training alleviates dyspnea in patients with heart failure. J Am Coll Cardiol 2002; 40: 1602-8.
49. Cider A, Tygesson H, Hedberg M, et al. Peripheral muscle training in patients with clinical signs of heart failure. Scand J Rehabil Med 1997; 29: 121-7.
50. Jankowska EA, Wȩgrzynowska K, Superlak M, et al. The 12-week progressive quadriceps resistance training improves muscle strength, exercise capacity and quality of life in patients with stable chronic heart failure. Int J Cardiol 2007; [Epub ahead of print].
51. Jankowska EA, Zaczyńska E, Czarny A, et al. Quadrceps resistance training concomitantly modifies autonomic balance and immune activation in patients with chronic hart failure. J Rehabil Med (in press).
52. Levinger I, Bronks R, Cody DV, et al. The effect of resistance training on left ventricular function and structure of patients with chronic heart failure. Int J Cardiol 2005; 105: 159-63.
53. Coats AJ. Origin symptoms in patients with cachexia with special reference to weakness and shortness of breath. Int J Cardiol 2002; 85: 133-9.
54. Harrington D, Anker SD, Chua TP, et al. Skeletal muscle function and its relation to exercise tolerance in chronic heart failure. J Am Coll Cardiol 1997; 30: 1758-64.
55. Anker SD, Swan JW, Volterrani M, et al. The influence of muscle mass, strength, fatigability and blood flow on exercise capacity in cachectic and non-cachectic patients with chronic heart failure. Eur Heart J 1997; 18: 259-69.
56. Minotti JR, Johnson EC, Hudson TL, et al. Skeletal muscle response to exercise training in congestive heart failure. J Clin Invest 1990; 86: 751-58.
57. Ponikowski P, Chua TP, Francis DP, et al. Muscle ergoreceptor overactivity reflects deterioration in clinical status and cardiorespiratory reflex control in chronic heart failure Circulation 2001; 104: 2324-30.
58. Scott A, Francis DP, Davies LC, et al. Contribution of skeletal muscle 'ergoreceptors' in the human leg to respiratory control in chronic heart failure. J Physiol 2000; 529 Pt 3: 863-70.
59. Grieve DA, Clark AL, McCann GP, et al. The ergoreflex in patients with chronic stable heart failure. Int J Cardiol 1999; 68: 157-64.
60. Piepoli M, Clark AL, Coats AJ. Muscle metaboreceptors in hemodynamic, autonomic, and ventilatory responses to exercise in men. Am J Physiol 1995; 269: 428-36.
61. Sullivan MJ, Cobb FR. Central hemodynamic response to exercise in patients with chronic heart failure. Chest 1992; 101 (5 Suppl): 340S-346S.
62. Kaczmarek A, Banasiak W, Ponikowski P. Przewlek?a niewydolnoś ć serca. Rola ergoreceptorów miȩśni szkieletowych. Kardiol Pol 2004; 60: 374-76.
63. Piepoli M, Clark AL, Volterrani M, et al. Contribution of muscle afferents to the hemodynamic, autonomic, and ventilatory responses to exercise in patients with chronic heart failure. Circulation 1996; 93: 940-52.
64. Ponikowski P, Francis DP, Piepoli MF, et al. Enhanced ventilatory response to exercise in patients with chronic heart failure and preserved exercise tolerance. Marker of abnormal cardiorespiratory reflex control and predictor of poor prognosis. Circulation 2001; 103: 967-72.
65. Piepoli M, Kaczmarek A, Francis DP, et al. Reduced peripheral skeletal muscle mass and abnormal reflex physiology in chronic heart failure. Circulation 2006; 114: 126-34.
66. Coats AJ. Exercise training in heart failure. Curr Control Trials Cardiovasc Med 2000; 1: 155-60.
67. Piepoli MF, Scott AC, Capucci A, et al. Skeletal muscle training in chronic heart failure. Acta Physiol Scand 2001; 171: 295-303.
68. Ko JK, McKelvie RS. The role of exercise training for patients with heart failure. Eura Medicophys; 41: 35-47.
69. Gunn E, Smith KM, McKelvie RS, et al. Exercise and the heart failure patient: aerobic vs strength training - is there a need for both? Prog Cardiovasc Nurs 2006; 21: 146-50.
70. Pu CT, Johnson MT, Forman DE, et al. Randomized trial of progressive resistance training to counteract the myopathy of chronic heart failure. J Appl Physiol 2001; 90: 2341-50.
71. Williams AD, Carey MF, Selig S, et al. Circuit resistance training in chronic heart failure improves skeletal muscle mitochondrial ATP production rate-a randomized controlled trial. J Cardiac Fail 2007; 13: 79-85.
72. King ML, Dracup KA, Fonarow GC. The hemodynamic effects of isotonic exercise using hand held weights in patients with heart failure. J Heart Lung Transplant 2000; 19: 1209-18.
73. Radzewitz A, Miche E, Herrmann G, et al. Exercise and muscle strength training and their effect on quality of life in patients with chronic heart failure. Eur J Heart Fail 2002; 4: 627-34.
74. Volaklis KA, Tokmakidis SP. Resistance exercise training in patients with heart failure. Sports Med 2005; 35: 1085-1103.
75. Meyer K. Resistance exercise in chronic heart failure - landmark studies and implications for practice. Clin Invest Med 2006; 29: 166-9.
76. Meyer K, Foster C, Georgakopoulos N. Comparison of left ventricular function during interval versus steady-state exercise training in patients with chronic congestive heart failure. Am J Cardiol 1998; 82: 1382-87.
77. Cheetham C, Green D, Collis J, et al. Effect of aerobic and resistance exercise on hemodynamic responses in severe chronic heart failure. J Appl Physiol 2002; 93: 175-80.
78. Conraads VM, Beckers P, Bosmans J. Combined endurance/resistance training reduces plasma TNF-alpha receptor levels in patients with chronic heart failure and coronary artery disease. Eur Heart J 2002; 23: 1854-60.
79. Delagardelle C, Feiereisen P, Krecké R, et al. Objective effects of a 6 months' endurance and strength training program in outpatients with congestive heart failure. Med Sci Sports Exerc 1999; 31: 1102-7.
80. Barnard KL, Adams KJ, Swank AM. Combined high-intensity strength and aerobic training in patients with congesive heart failure. J Strength Cond Res 2000; 14: 383-8.
81. Adams KJ, Barnard KL, Swank AM. Combined high-intensity strength and aerobic training in diverse phase II cardiac rehabilitation patients. J Cardiopulm Rehabil 1999; 19: 209-215.
82. Maiorana A, O'Driscoll G, Dembo L, Effect of aerobic and resistance exercise training on vascular function in heart failure. Am J Physiol Heart Circ Physiol 2000; 279: H1999-2005.
83. Maiorana A, O'Driscoll G, Cheetham C, et al. Combined aerobic and resistance exercise training improves functional capacity and strength in CHF. J Appl Physiol 2000; 88: 1565-70.
84. Conraads VM, Beckers P, Vaes J, et al. Combined endurance/resistance training reduces NT-proBNP levels in patients with chronic heart failure. Eur Heart J 2004; 25: 1797-805.
85. Selig SE, Carey MF, Menzies DG. Moderate-intensity resistance exercise training in patients with chronic heart failure improves strength, endurance, heart rate variability and forearm strength blood flow. J Card Fail 2004; 10: 21-30.
86. Levinger I, Bronks R, Cody DV et al. Resistance training for chronic heart failure patients on beta blocker medications. Int J Cardiol 2005; 102: 493-9.
87. Grosse T, Kreulich K, Naegele H. Peripheral muscular strength training in patients with severe heart failure. Dtsch Z Sportmed 2001; 52: 11-4.
88. Magnusson G, Gordon A, Kaijser L. High intensity knee extensor training, in patients with chronic heart failure. Major skeletal muscle improvement. Eur Heart J 1996: 17: 1048-55.
89. Jónsdóttir S, Andersen KK, Sigurosson AF, Sigurosson SB. The effect of physical training in chronic heart failure. Eur J Heart Fail 2006; 8: 97-101.
90. Gordon A, Tyni-Lenné R, Jansson E, et al. Beneficial effects of exercise training in heart failure patients with low cardiac output response to exercise - a comparison of two training models. J Int Med 1999; 246: 175-82.
91. Hare DL, Ryan TM, Selig SE, et al. Resistance exercise training increases muscle strength, endurance, and blood flow in patients with chronic heart failure. Am J Cardiol 1999; 83: 1674-7, A7.
92. Meyer K, Hajric R, Westbrook S. Hemodynamic responses during leg press exercise in patients with chronic congestive heart failure. Am J Cardiol 1999; 83: 1537-43.